Ligand Pharmaceuticals Incorporated is a company in the U.S. stock market and it is a holding in 74 U.S.-traded ETFs. LGND has around 2.7M shares in the U.S. ETF market. The largest ETF holder of LGND is the SPDR S&P Biotech ETF (XBI), with approximately 524.76K shares. Investors may also find of interest that the ETF with the largest allocation to LGND stock is Invesco Dynamic Pharmaceuticals ETF (PJP), with a portfolio weight of 2.89%. On average, U.S. ETFs allocate 0.27% of LGND to their portfolios.
Additionally, LGND is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with LGND as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.